Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $261B |
| FY2017, ended Dec 31, 2017 | $239B |
| FY2018, ended Dec 31, 2018 | $208B |
| FY2019, ended Dec 31, 2019 | $280B |
| FY2020, ended Dec 31, 2020 | $205B |
| FY2021, ended Dec 31, 2021 | $176B |
| FY2022, ended Dec 31, 2022 | $131B |
| FY2023, ended Dec 31, 2023 | $120B |
| FY2024, ended Dec 31, 2024 | $163B |
| FY2025, ended Dec 31, 2025 | $174B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $164B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $164B |
| FY2017, ended Dec 31, 2017 | $161B |
| FY2018, ended Dec 31, 2018 | $171B |
| FY2019, ended Dec 31, 2019 | $181B |
| FY2020, ended Dec 31, 2020 | $143B |
| FY2021, ended Dec 31, 2021 | $134B |
| FY2022, ended Dec 31, 2022 | $121B |
| FY2023, ended Dec 31, 2023 | $122B |
| FY2024, ended Dec 31, 2024 | $122B |
| FY2025, ended Dec 31, 2025 | $126B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $129B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $13.0B | $16.9B |
| FY2017, ended Dec 31, 2017 | $29.4B | $17.4B |
| FY2018, ended Dec 31, 2018 | $19.4B | $22.4B |
| FY2019, ended Dec 31, 2019 | $13.9B | $29.0B |
| FY2020, ended Dec 31, 2020 | −$5.18B | $28.4B |
| FY2021, ended Dec 31, 2021 | $20.1B | $26.4B |
| FY2022, ended Dec 31, 2022 | −$8.52B | $16.2B |
| FY2023, ended Dec 31, 2023 | $14.4B | $20.5B |
| FY2024, ended Dec 31, 2024 | $10.9B | $18.5B |
| FY2025, ended Dec 31, 2025 | $22.0B | $19.4B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $13.1B | $17.8B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.79B |
| FY2017, ended Dec 31, 2017 | $50.5B |
| FY2018, ended Dec 31, 2018 | $5.20B |
| FY2019, ended Dec 31, 2019 | $9.70B |
| FY2020, ended Dec 31, 2020 | $7.92B |
| FY2021, ended Dec 31, 2021 | $19.2B |
| FY2022, ended Dec 31, 2022 | $3.70B |
| FY2023, ended Dec 31, 2023 | $6.72B |
| FY2024, ended Dec 31, 2024 | $3.30B |
| FY2025, ended Dec 31, 2025 | $18.2B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $10.8B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $124B |
| FY2017, ended Dec 31, 2017 | $164B |
| FY2018, ended Dec 31, 2018 | $177B |
| FY2019, ended Dec 31, 2019 | $161B |
| FY2020, ended Dec 31, 2020 | $155B |
| FY2021, ended Dec 31, 2021 | $174B |
| FY2022, ended Dec 31, 2022 | $134B |
| FY2023, ended Dec 31, 2023 | $135B |
| FY2024, ended Dec 31, 2024 | $122B |
| FY2025, ended Dec 31, 2025 | $135B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $160B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 9.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 6.14B |
| FY2017, ended Dec 31, 2017 | 6.14B |
| FY2018, ended Dec 31, 2018 | 7.29B |
| FY2019, ended Dec 31, 2019 | 7.17B |
| FY2020, ended Dec 31, 2020 | 7.13B |
| FY2021, ended Dec 31, 2021 | 7.14B |
| FY2022, ended Dec 31, 2022 | 7.13B |
| FY2023, ended Dec 31, 2023 | 7.15B |
| FY2024, ended Dec 31, 2024 | 7.18B |
| FY2025, ended Dec 31, 2025 | 7.00B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 6.74B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $512M | $653M |
| FY2017, ended Dec 31, 2017 | $463M | $480M |
| FY2018, ended Dec 31, 2018 | $609M | $463M |
| FY2019, ended Dec 31, 2019 | $2.42B | $819M |
| FY2020, ended Dec 31, 2020 | $5.50B | $422M |
| FY2021, ended Dec 31, 2021 | $202M | $447M |
| FY2022, ended Dec 31, 2022 | $890M | $518M |
| FY2023, ended Dec 31, 2023 | $194M | $479M |
| FY2024, ended Dec 31, 2024 | $215M | $505M |
| FY2025, ended Dec 31, 2025 | $4.50B | $536M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $9.30B | — |
Valuation
At current price- Market Cap
- $141B
- P/E
- 10.7×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.1×
- Price / Book
- 1.1×
- EV / EBITDA
- 6.6×
Growth
Trailing 12 months- Revenue (TTM)
- $129B
- Revenue Growth YoY
- 3.5%
- Revenue CAGR 3Y
- 1.3%
- Revenue CAGR 5Y
- −2.6%
- EPS Growth YoY
- −39.4%
- Net Income Growth YoY
- −41.0%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 18.3%
- Net Margin
- 10.2%
- FCF Margin
- 13.8%
- Return on Equity
- 10.5%
Earnings
Trailing 12 months- Net Income
- $13.1B
- EPS (diluted)
- $1.86
- EBITDA
- $43.6B
- Operating Income
- $23.6B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $10.8B
- Total Debt
- $160B
- Net Debt
- $149B
- Total Assets
- $446B
- Total Liabilities
- $323B
- Shareholders' Equity
- $123B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $40.2B
- Capital Expenditure
- $22.4B
- Free Cash Flow
- $17.8B
Dividends and risk
Last 12 months- Dividend Yield
- 5.3%
- Dividend / Share
- $1.11
- Beta (5Y)
- 0.24
Every ratio is calculated from the company’s reported figures.